Organovo Holdings, Inc.
ONVO
Rang in Aktien
#36036
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Aktienkurs
$2.00
Zuletzt synchronisiert: 2025-05-19
Marktkapitalisierung
$2.93M
Veränderung (1 Tag)
-3.38%
Veränderung (1 Jahr)
656.14%
Land
US
Handel Organovo Holdings, Inc. (ONVO)
Kategorie
Healthcare
Kursverlauf für Organovo Holdings, Inc. (ONVO)
Höchster Schlusskurs: $5.13 am 2025-03-01
Niedrigster Schlusskurs: $131.45 am 2014-11-01
Niedrigster Schlusskurs: $131.45 am 2014-11-01
Kursverlauf der Aktie von Organovo Holdings, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.04 | -4.33% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
